Norman J. Scherzer

Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry

Jerry Call, Christopher D Walentas, Jens C. Eickhoff et al. · BMC Cancer · 2012 · 49 citations · Full text

Medicine, Oncology, Pathology +17

Survival in advanced GIST has improved over time and correlates with increased access to post-imatinib tyrosine kinase inhibitors: results from Life Raft Group Registry

Jerry Call, Yu Wang, Denisse Montoya et al. · Clinical Sarcoma Research · 2019 · 31 citations · Full text

Medicine, Oncology, Pharmacology +9

Evaluation of Self-Reported Progression and Correlation of Imatinib Dose to Survival in Patients with Metastatic Gastrointestinal Stromal Tumors: An Open Cohort Study

Jerry Call, Norman J. Scherzer, P. David Josephy et al. · Journal of Gastrointestinal Cancer · 2009 · 12 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry

Emelia Stuart, Sudeep Banerjee, Jorge de la Torre et al. · Journal of Surgical Oncology · 2019 · 12 citations · Full text

Medicine, Oncology, Pathology +13